In-vitro model systems to study Hepatitis C Virus

Genetic Vaccines and Therapy

Volumn 9, Issue , 2011, Pages

  Ashfaq, Usman A ^a   Khan, Shaheen N ^a   Nawaz, Zafar ^b   Riazuddin, Sheikh ^c  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; GLYCOPROTEIN E1; GLYCOPROTEIN E2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B;

ENDOCYTOSIS; GENE MUTATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; VIRUS ENTRY; VIRUS GENOME; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 79953672428     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-9-7     Document Type: Review

References (33)

1. Raja NSJK, Janjua KA. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect. J Microbiol Immunol Infect 2008, 41:4-8.
2. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001, 35:666-678. 10.1016/S0168-8278(01)00179-9, 11690716.
3. Beaulieu PL, Tsantrizos YS. Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections. Curr Opin Investig Drugs 2004, 5:838-850.
4. De Francesco R, Tomei L, Altamura S, Summa V, Migliaccio G. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res 2003, 58:1-16. 10.1016/S0166-3542(03)00028-7, 12719002.
5. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995, 15:41-63. 10.1055/s-2007-1007262, 7597443.
6. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993, 74(Pt 11):2391-2399. 10.1099/0022-1317-74-11-2391, 8245854.
7. McOmish F, Yap PL, Dow BC. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994, 32:884-892. 263157, 7913097.
8. Nousbaum JB, Pol S, Nalpas B, Group A. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995, 122:161-168.
9. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008, 8:69. 10.1186/1471-2334-8-69, 2409346, 18498666.
10. Flamm SL. Chronic hepatitis C virus infection. Jama 2003, 289:2413-2417. 10.1001/jama.289.18.2413, 12746366.
11. Cornberg M, Wedemeyer H, Manns MP. Treatment of chronic hepatitis C with PEGylated interferon and ribavirin. Curr Gastroenterol Rep 2002, 4:23-30. 10.1007/s11894-002-0034-y, 11825538.
12. Khakoo S, Glue P, Grellier L, Wells B, Bell A, Dash C, Murray-Lyon I, Lypnyj D, Flannery B, Walters K, Dusheiko GM. Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. Br J Clin Pharmacol 1998, 46:563-570. 10.1046/j.1365-2125.1998.00836.x, 1873804, 9862245.
13. Russo MW, Fried MW. Side effects of therapy for chronic hepatitis C. Gastroenterology 2003, 124:1711-1719. 10.1016/S0016-5085(03)00394-9, 12761728.
14. Iacovacci S, Manzin A, Barca S, Sargiacomo M, Serafino A, Valli MB, Macioce G, Hassan HJ, Ponzetto A, Clementi M, et al. Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology 1997, 26:1328-1337.
15. Lazaro CA, Chang M, Tang W, Campbell J, Sullivan DG, Gretch DR, Corey L, Coombs RW, Fausto N. Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol 2007, 170:478-489. 10.2353/ajpath.2007.060789, 1851861, 17255316.
16. Song ZQ, Hao F, Min F, Ma QY, Liu GD. Hepatitis C virus infection of human hepatoma cell line 7721 in vitro. World J Gastroenterol 2001, 7:685-689.
17. Kato N, Ikeda M, Mizutani T, Sugiyama K, Noguchi M, Hirohashi S, Shimotohno K. Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes. Jpn J Cancer Res 1996, 87:787-792.
18. Seipp S, Mueller HM, Pfaff E, Stremmel W, Theilmann L, Goeser T. Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol 1997, 78(Pt 10):2467-2476.
19. Mizutani T, Kato N, Saito S, Ikeda M, Sugiyama K, Shimotohno K. Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2. J Virol 1996, 70:7219-7223. 190776, 8794370.
20. Shimizu YK, Igarashi H, Kiyohara T, Shapiro M, Wong DC, Purcell RH, Yoshikura H. Infection of a chimpanzee with hepatitis C virus grown in cell culture. J Gen Virol 1998, 79(Pt 6):1383-1386.
21. Ito T, Mukaigawa J, Zuo J, Hirabayashi Y, Mitamura K, Yasui K. Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. J Gen Virol 1996, 77(Pt 5):1043-1054. 10.1099/0022-1317-77-5-1043, 8609470.
22. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000, 290:1972-1974. 10.1126/science.290.5498.1972, 11110665.
23. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285:110-113. 10.1126/science.285.5424.110, 10390360.
24. Lohmann V, Hoffmann S, Herian U, Penin F, Bartenschlager R. Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol 2003, 77:3007-3019. 10.1128/JVI.77.5.3007-3019.2003, 149776, 12584326.
25. Bartenschlager R. Hepatitis C virus replicons: potential role for drug development. Nat Rev Drug Discov 2002, 1:911-916. 10.1038/nrd942, 12415250.
26. Bukh J, Pietschmann T, Lohmann V, Krieger N, Faulk K, Engle RE, Govindarajan S, Shapiro M, St Claire M, Bartenschlager R. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci USA 2002, 99:14416-14421. 10.1073/pnas.212532699, 137898, 12391335.
27. Pietschmann T, Lohmann V, Rutter G, Kurpanek K, Bartenschlager R. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol 2001, 75:1252-1264. 10.1128/JVI.75.3.1252-1264.2001, 114031, 11152498.
28. Blight KJ, McKeating JA, Marcotrigiano J, Rice CM. Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 2003, 77:3181-3190. 10.1128/JVI.77.5.3181-3190.2003, 149761, 12584342.
29. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005, 11:791-796. 10.1038/nm1268, 2918402, 15951748.
30. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626. 10.1126/science.1114016, 15947137.
31. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005, 102:9294-9299. 10.1073/pnas.0503596102, 1166622, 15939869.
32. Cai Z, Zhang C, Chang KS, Jiang J, Ahn BC, Wakita T, Liang TJ, Luo G. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J Virol 2005, 79:13963-13973. 10.1128/JVI.79.22.13963-13973.2005, 1280219, 16254332.
33. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 2003, 100:7271-7276. 10.1073/pnas.0832180100, 165865, 12761383.